Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 May;19(5):29.
doi: 10.1007/s11926-017-0656-6.

Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review

Affiliations
Case Reports

Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review

Birgit A Mosheimer et al. Curr Rheumatol Rep. 2017 May.

Abstract

Purpose of review: Rosai-Dorfman disease (RDD) is a rare histiocytic disorder typically presenting as painless cervical lymphadenopathy. Extranodal involvement is common and may also affect bones. Here, we present a patient with typical nodal disease and multifocal bone manifestations. Further, a systematic literature review was performed to better understand the phenotype, clinical course and treatment options of such patients.

Recent findings: RDD is a nonmalignant, classically sporadic histiocytosis. Nevertheless, increasing evidence also suggests familial forms of the disease. According to our literature review, bone involvement is exceedingly rare and heterogeneous. Clinical outcome in terms of mortality seems to be favorable in most cases. Currently, therapy strategies include surgical and immunosuppressive treatments, but the optimal treatment of osseous RDD remains to be defined. Patients with osseous RDD may present to rheumatologists with arthralgia or arthritis. Due to the rarity of the disease, diagnosis and treatment remain challenging.

Keywords: Bone involvement; Rosai-Dorfman disease; Treatment strategies.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Dr. Mosheimer-Feistritzer, Dr. Weiss, Dr. Zandieh, Dr. Oppl and Dr. Fillitz declare that they have no conflict of interest.

Dr. Zwerina reports grants from Roche, outside the submitted work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Figures

Fig. 1
Fig. 1
Bone involvement in Rosai-Dorfman disease (RDD). X-ray of the hands shows a lytic lesion (arrow) of the left distal radius (a). MRI demonstrated an additional mass lesion (dotted arrow) involving the proximal part of the right second phalanx with soft tissue extension (b)
Fig. 2
Fig. 2
Distribution of bone manifestations in reported RDD patients (n = 108)
Fig. 3
Fig. 3
Distribution of extraosseus involvement (n = 80) in reported RDD patients

References

    1. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7(1):19–73. - PubMed
    1. McClain KL, Natkunam Y, Swerdlow SH. Atypical cellular disorders. Hematology Am Soc Hematol Educ Program. 2004:283–96. - PubMed
    1. Hervier B, Haroche J, Arnaud L, Charlotte F, Donadieu J, Neel A, et al. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Blood. 2014;124(7):1119–1126. doi: 10.1182/blood-2013-12-543793. - DOI - PubMed
    1. Weitzman S, Jaffe R. Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses. Pediatr Blood Cancer. 2005;45(3):256–264. doi: 10.1002/pbc.20246. - DOI - PubMed
    1. • Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016. Classification of RDD within histiocytic diseases, also giving insight into genetics. - PMC - PubMed